1hon MSN
Glaukos outlines $600M–$620M 2026 revenue outlook as Epioxa launch and iDose TR drive growth
U.S. Glaucoma net sales reached $80.8 million, with iDose TR contributing approximately $40 million. International Glaucoma net sales were $29.4 million, and Corneal Health franchise net sales totaled ...
Q3 2025 Management View CEO Scott Boatwright stated that "our third quarter performance fell short of our expectations due to persistent macroeconomic pressures. However, we are moving quickly with a ...
The early response to new Crusader Kings 3 DLC All Under Heaven is strong, with users praising its performance and systems in ...
Q3 2025 Management View CEO Mohammad Abu-Ghazaleh highlighted “continued gross margin expansion in our fresh and value-added ...
As Nebraska turns a state prison into a detention center for migrants facing deportation proceedings, the Nebraska ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results